Prime Formula
Natural health product licensed in Canada
- Other names
- VITAMOST® PRIME¿
- Licence holder
- The Results Company Inc.
- NPN or DIN-HM
- 02238834
- Status
- Active licence
- Licence date
- 22 August 2008
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada (5 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Magnésium: up to 500 mg a day according to the dosing instructions published by Health Canada (5 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 300 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 200 µg a day according to the dosing instructions published by Health Canada (5 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 25 mg a day according to the dosing instructions published by Health Canada (5 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine C: up to 1,500 mg a day according to the dosing instructions published by Health Canada (5 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Potassium: up to 400 mg a day according to the dosing instructions published by Health Canada (5 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 80 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- À vérifier
Magnésium: up to 500 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSA for adults (250 mg a day). Pour ce nutriment, le repère de l'EFSA ne porte que sur les apports ajoutés (compléments, aliments enrichis), pas sur ce qu'apporte l'alimentation courante.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine A Source : Palmitate de vitamine A Potency : 2,000 UI Vitamin A | 604.4 mcg EAR | Not calculated |
| Niacinamide Source : Niacinamide | 10 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 10 mg | 50,000 µg |
| Magnésium Source : Oxyde de magnésium | 100 mg | 500,000 µg |
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 40 mcg | 200 µg |
| Riboflavine Source : Riboflavine | 10 mg | 50,000 µg |
| Zinc Source : Gluconate de zinc | 5 mg | 25,000 µg |
| Vitamine C Source : Acide ascorbique | 300 mg | 1,500,000 µg |
| Thiamine Source : Mononitrate de thiamine | 10 mg | 50,000 µg |
| Biotine Source : Biotine | 24 mcg | 120 µg |
| Vanadium Source : Produit de chélation de vanadium et de PVH | 2 mcg | Not calculated |
| Molybdène Source : Molybdate de sodium | 4.4 mcg | 22 µg |
| Potassium Source : Chlorure de potassium | 80 mg | 400,000 µg |
| Vitamine D3 Source : Cholécalciférol Potency : 160 UI Vitamin D | 4 mcg | Not calculated |
| Vitamine B12 Source : Cyanocobalamine | 66 mcg | 330 µg |
Non-medicinal ingredients
Shilajit, Croscarmellose de sodium, Chlorhydrate de bétaïne, Acide stéarique, Bioflavonoïdes de citron, Microcrystalline cellulose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 5 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Multi-Vitamin/Mineral Supplement. A factor for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have a liver disorder. Consult a health care practitioner prior to use if you have a history of non-melanoma skin cancer. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Keep out of reach of children. There is enough drug in this package to seriously harm a child.
Source
Official Health Canada record, licence 02238834
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.